Track topics on Twitter Track topics that are important to you
This week’s announcements include the retirement of GlaxoSmithKline’s CFO, new CEOs at Complexa, Synlogic and Horizon Discovery, and other new...
Tagrisso shines for AstraZeneca in the first quarter and the company is on track for approval of a fifth new...
The pharmaceutical sector has given its backing to a report from MPs which warns that a no-deal Brexit will have...
-Founder of Acerta Pharma to lead Complexa as it advances Phase 2 clinical development of lead compound CXA-10 in two orphan indications- Complexa Inc., a clinical stage bioph...
Complexa Inc. today announced dosing of the first patient in FIRSTx, a Phase 2 clinical trial evaluating the safety and efficacy of the company’s lead candidate, CXA-10, to trea...
Complexa, Inc. is a platform biopharmaceutical company researching and developing endogenous human cell signaling technologies targeting an array of prevalent inflammatory and met...
Complexa Inc. is a patient-focused, science-driven, clinical stage biopharmaceutical company developing a novel class of compounds, nitrated fatty acids (NFAs), for the safe and e...
We have published hundreds of Complexa Inc. news stories on BioPortfolio along with dozens of Complexa Inc. Clinical Trials and PubMed Articles about Complexa Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Complexa Inc. Companies in our database. You can also find out about relevant Complexa Inc. Drugs and Medications on this site too.
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...